XNCR

Biotechnology INCY Uncategorized XNCR

Incyte marks late-stage trial win for Xencor-partnered lymphoma therapy

Jan 5, 2026

Biotechnology INCY Uncategorized XNCR

Incyte announces EU approval of Xencor-partnered lymphoma therapy

Dec 17, 2025